GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modern Chinese Medicine Group Co Ltd (HKSE:01643) » Definitions » Shares Outstanding (EOP)

Modern Chinese Medicine Group Co (HKSE:01643) Shares Outstanding (EOP) : 600.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Modern Chinese Medicine Group Co Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Modern Chinese Medicine Group Co's shares outstanding for the quarter that ended in Dec. 2023 was 600.0 Mil.

Modern Chinese Medicine Group Co's quarterly shares outstanding stayed the same from Jun. 2023 (600.0 Mil) to Dec. 2023 (600.0 Mil).

Modern Chinese Medicine Group Co's annual shares outstanding stayed the same from Dec. 2022 (600.0 Mil) to Dec. 2023 (600.0 Mil).


Modern Chinese Medicine Group Co Shares Outstanding (EOP) Historical Data

The historical data trend for Modern Chinese Medicine Group Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modern Chinese Medicine Group Co Shares Outstanding (EOP) Chart

Modern Chinese Medicine Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial 600.00 600.00 600.00 600.00 600.00

Modern Chinese Medicine Group Co Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 600.00 600.00 600.00 600.00 600.00

Competitive Comparison of Modern Chinese Medicine Group Co's Shares Outstanding (EOP)

For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Chinese Medicine Group Co's Shares Outstanding (EOP) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Modern Chinese Medicine Group Co's Shares Outstanding (EOP) falls into.



Modern Chinese Medicine Group Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Modern Chinese Medicine Group Co  (HKSE:01643) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Modern Chinese Medicine Group Co Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Modern Chinese Medicine Group Co (HKSE:01643) Business Description

Traded in Other Exchanges
N/A
Address
No. 88 Jinwei Road, Hebei, Chengde, CHN, 068150
Modern Chinese Medicine Group Co Ltd is engaged in the production of proprietary Chinese medicine. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, and Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxification Pill. The Group has one operating segment of its business as a whole as the production of PCM. Geographically, the majority is from PRC.
Executives
Sun Xinlei 2201 Interest of corporation controlled by you
Xian Dai Sheng Wu Ke Ji Ji Tuan Kong Gu You Xian Gong Si 2101 Beneficial owner
Xie Wei 2201 Interest of corporation controlled by you

Modern Chinese Medicine Group Co (HKSE:01643) Headlines

No Headlines